US Patent 7834041 Dual-acting antihypertensive agents
Patent 7834041 was granted and assigned to Theravance on November, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+69 characters)
Article
Patent abstract
The invention relates to compounds having the formula:
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Paul R. Fatheree0
Robert Murray McKinnell0
Roland Gendron0
Ryan Hudson0
Seok-Ki Choi0
Vivek Sasikumar0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07834041 Dual-acting antihypertensive agents US Patent 7834041 Dual-acting antihypertensive agents
Infobox
Patent Number
078340410
Patent Number
78340410
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078340410
Date of Patent
November 16, 2010
0Patent Application Number
122318580
Date Filed
September 5, 2008
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07834041 Dual-acting antihypertensive agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07834041
Date of patent
November 16, 2010
Patent application number
12231858
Date Filed
September 5, 2008
Patent primary examiner
Find more entities like US Patent 7834041 Dual-acting antihypertensive agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
